TACSTD2 and cancer: We analyzed comprehensive genomic data across numerous solid tumor types from TCGA to examine Trop-2 mRNA expression and determine the relative expression of Trop-2 in NSCLC in a pan-cancer comparison of 32 solid tumor indications.